Literatura académica sobre el tema "Low molecular weight heparin"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Low molecular weight heparin".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Low molecular weight heparin"
&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1414 (agosto de 2012): 28–29. http://dx.doi.org/10.2165/00128415-201214140-00091.
Texto completo&NA;. "Heparin/low-molecular-weight heparins". Reactions Weekly &NA;, n.º 1198 (abril de 2008): 22. http://dx.doi.org/10.2165/00128415-200811980-00068.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1210 (julio de 2008): 18. http://dx.doi.org/10.2165/00128415-200812100-00051.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1211 (julio de 2008): 17–18. http://dx.doi.org/10.2165/00128415-200812110-00053.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1211 (julio de 2008): 18. http://dx.doi.org/10.2165/00128415-200812110-00056.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1277 (noviembre de 2009): 23. http://dx.doi.org/10.2165/00128415-200912770-00068.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 1231 (diciembre de 2008): 16–17. http://dx.doi.org/10.2165/00128415-200812310-00049.
Texto completo&NA;. "Heparin/low molecular weight heparins". Reactions Weekly &NA;, n.º 989 (febrero de 2004): 10. http://dx.doi.org/10.2165/00128415-200409890-00030.
Texto completoMulloy, Barbara, Trevor Barrowcliffe y Elaine Gray. "Heparin and low-molecular-weight heparin". Thrombosis and Haemostasis 99, n.º 11 (2008): 807–18. http://dx.doi.org/10.1160/th08-01-0032.
Texto completoHoppensteadt, Debra, Jeanine M. Walenga, Jawed Fareed y Rodger L. Bick. "Heparin, low–molecular-weight heparins, and heparin pentasaccharide". Hematology/Oncology Clinics of North America 17, n.º 1 (febrero de 2003): 313–41. http://dx.doi.org/10.1016/s0889-8588(02)00091-6.
Texto completoTesis sobre el tema "Low molecular weight heparin"
Hettiarachchi, Rohan Jagath Kumara. "Venous thromboembolism, cancer and low molecular weight heparin". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/84386.
Texto completoMatthíasson, Stefán E. "Low molecular weight heparin and dextran in thromboprophylaxis human and experimental studies /". Malmö : Dept. of Surgery, Lund University, Malmö General Hospital, 1994. http://books.google.com/books?id=9OxsAAAAMAAJ.
Texto completoVecchietti, D. G. "Low Molecular Weight Heparins : in depth structural characterization to understand their different biological properties". Doctoral thesis, Università degli Studi di Milano, 2008. http://hdl.handle.net/2434/59669.
Texto completoMauron, Thomas. "Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins /". Bern : Hämatologisches Zentrallabor der Universität Inselspital, 1998. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.
Texto completoGandara, Esteban. "Is an Intermediate Dose of LMWH Effective for Secondary Prevention of Recurrent Venous Thromboembolism in Pregnant Patients Diagnosed with Deep Vein Thrombosis or Pulmonary Embolism? Design of a Pilot Study". Thèse, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23388.
Texto completoHolmström, Margareta. "Clinical aspects on treatment of deep venous thrombosis with a low molecular weight heparin /". Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-2989-0/.
Texto completoNäsström, Birgit. "Lipoprotein lipase in hemodialysis patients and healthy controls : effects of heparin /". Umeå : Univ, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-340.
Texto completoSteward, David W., John B. Bossaer, Brian Odle, Emily Flores y Somi Rikhye. "Prescribing of Low-Molecular-Weight Heparin and Warfarin in Patients with Acute Venous Thromboembolism and Active Cancer". Digital Commons @ East Tennessee State University, 2014. https://dc.etsu.edu/etsu-works/2322.
Texto completoPranckevičienė, Gabrielė. "Pharmacoepidemiologic assessment of low-molecular-weight heparins utilization in Lithuania and development of pharmacoeconomic model". Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2014. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2014~D_20140305_141832-70667.
Texto completoPastaraisiais metais daugelyje šalių sveikatos priežiūros išlaidos augo daug greičiau nei bendras gerovės lygis, todėl yra nuolat diskutuojama, kaip šį išlaidų augimą reikėtų kontroliuoti. Darbo uždaviniai: 1) atlikti heparinų preparatų meta-analizę, palyginant jų efektyvumo ir saugumo parametrus bei gydymo baigtis; 2) atlikti heparinų preparatų ilgalaikio suvartojimo Lietuvoje farmakoepidemiologinį tyrimą; 3) suformuluoti farmakoekonominį kaštų mažinimo sprendimų modelį mažos molekulinės masės heparinų preparatų grupei, remiantis referentinės kainos metodika; 4) ištirti heparinų preparatų skyrimo tendencijas antrinio lygio klinikinėje ligoninėje ir palyginti heparinų preparatų skyrimo atitikimą tarptautinėms gairėms. Meta-analizės rezultatai parodė, jog mažos molekulinės masės heparinai gali būti tarpusavyje pa¬keičiami dėl analogiškų terapinių savybių tam tikrose indikacijose. Heparinų preparatų suvartojimas ir atitinkamos išlaidos tiriamuoju laikotarpiu Lietuvoje nuolat didėjo, todėl būtų aktualu taikyti šiuolaikines farmakoekonomines išlaidų reguliavimo metodikas. Pritaikius kaštų mažinimo modelį heparinų preparatų grupei, būtų galima sumažinti išlaidas šios grupės preparatams beveik 70 procentų. Farmakoepidemiologinio tyrimo rezultatai atskleidė, jog heparinų preparatų skyrimo praktika klinikinėje ligoninėje buvo nepakankamai reglamentuota. Taip pat heparinų preparatų saugumo parametrų stebėjimo praktika ligoninėje neatitiko tarptautinių rekomendacijų.
Lima, Juliana Pego. "Development of Nanoparticles as Low Molecular Weight Heparins Carriers for Oral Administration". Master's thesis, Faculdade de Farmácia da Universidade do Porto, 2007. http://hdl.handle.net/10216/7486.
Texto completoLibros sobre el tema "Low molecular weight heparin"
Barrowcliffe, Trevor W. Low molecular weight heparin. Chichester, West Sussex, England: Wiley, 1992.
Buscar texto completoHyers, Thomas M. Treatment handbook of low-molecular-weight heparin. London: Science Press, 2000.
Buscar texto completoThromoprophylaxis with low-molecular-weight heparins. London: Current Medicine Group, 2006.
Buscar texto completoChristian, Doutremepuich, ed. Low molecular weight heparins in clinical practice. New York: Dekker, 1992.
Buscar texto completo1940-, Kher André, Sarret Monique 1938- y Toulemonde Francis 1926-, eds. Low molecular weight heparin therapy: An evaluation of clinical trials evidence. New York: Marcel Dekker, 1999.
Buscar texto completoHolmer, Erik. Heparin and its low molecular weight derivatives: Basic and applied studies in the development of a new antithrombotic drug. Uppsala: Sveriges Lantbruksuniversitet, 1987.
Buscar texto completoMaguire, Jacinta Marie. Low molecular weight heparin regime or unfractionated heparin and as pirin in the treatment of unstable angina. [S.l: The Author], 1994.
Buscar texto completoShukla, Vijay K. Low molecular weight heparins for major orthopedic surgery: A case for clinical outcomes. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 1998.
Buscar texto completoKampen, Thorsten U. Low Molecular Weight Organic Semiconductors. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2010. http://dx.doi.org/10.1002/9783527629978.
Texto completoBäckvall, Helena y Janne Lehtiö, eds. The Low Molecular Weight Proteome. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7209-4.
Texto completoCapítulos de libros sobre el tema "Low molecular weight heparin"
Davis, James W., Dana Forman, La Scienya M. Jackson, James W. Davis, Javier Garau, David N. O’Dwyer, Elisa Vedes et al. "Low Molecular Weight Heparin". En Encyclopedia of Intensive Care Medicine, 1341–43. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_716.
Texto completoPineo, G. F. y R. D. Hull. "Low Molecular Weight Heparin". En Antithrombotics, 305–29. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59942-2_10.
Texto completoMalloy, Rhynn J., Jessica Rimsans, Megan Rhoten, Katelyn Sylvester y John Fanikos. "Unfractionated Heparin and Low-Molecular-Weight Heparin". En Anticoagulation Therapy, 31–57. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-73709-6_3.
Texto completoStromich, Ashley. "Unfractionated Heparin and Low Molecular Weight Heparin". En Anticoagulation Management, 53–75. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22602-6_3.
Texto completoCombs, David J. y Lisa Leffert. "Low Molecular Weight Heparin, Unfractionated Heparin and Neuraxial Anaesthesia". En Quick Hits in Obstetric Anesthesia, 329–35. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-72487-0_49.
Texto completoGray, Elaine. "Standardisation of Unfractionated and Low-Molecular-Weight Heparin". En Heparin - A Century of Progress, 65–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-23056-1_4.
Texto completoGuerrini, Marco y Antonella Bisio. "Low-Molecular-Weight Heparins: Differential Characterization/Physical Characterization". En Heparin - A Century of Progress, 127–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-23056-1_7.
Texto completoElliott, C. Gregory. "Low Molecular Weight Heparins". En Pulmonary Embolism, 161–71. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-66893-0_12.
Texto completoMousa, Shaker A. "Heparin and Low-Molecular Weight Heparins in Thrombosis and Beyond". En Anticoagulants, Antiplatelets, and Thrombolytics, 109–32. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-803-4_3.
Texto completoIqbal, Zafar, Omar Hasan y Marc Cohen. "Unfractionated Heparin and Low Molecular Weight Heparin in Ischemic Heart Disease". En Therapeutic Advances in Thrombosis, 111–27. Oxford, UK: Blackwell Publishing Ltd., 2012. http://dx.doi.org/10.1002/9781118410875.ch8.
Texto completoActas de conferencias sobre el tema "Low molecular weight heparin"
Ordu, Y., J. Augustin, E. V. Hodenberg, V. Bode y J. Harenberg. "COMPARATIVE CLINICAL PHARMACOLOGY OF LOW MOLECULAR WEIGHT HEPARINS IN MAN". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643228.
Texto completoFareed, J., J. M. Walenga, D. Hoppensteadt, R. N. Emanuele y A. Racanell. "PHARMACOLOGIC INEQUIVALENCE OF LOW MOLECULAR WEIGHT HEPARINS". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644163.
Texto completoLasker, S. E., B. Y. Lee y R. E. Madden. "LOW MOLECULAR WEIGHT HEPARINS s ORAL ABSORPTION IN MONKEYS". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644855.
Texto completoZimmerman, R. A., C. T. Rieger, K. Hübner, C. W. Harenber y W. Kübler. "EXPERIMENTAL THROMBUS FORMATION AND HAEMOSTASIS OF DIFFERENT LOW MOLECULAR WEIGHT HEPARINS AND DOSAGES". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644162.
Texto completoMätzsch, T., D. Berggvist, U. Hedner, B. Nilsson y P. Østergaard. "INDUCTION OF OSTEOPOROSIS IN RATS BY STANDARD HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642930.
Texto completoGiese, Ch, A. Knodler, R. Zimmermann y J. Harenberg. "A NEW ONE STAGE CLOTTING ASSAY FOR HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644851.
Texto completoSakuragawa, N., T. Shimotori y K. Takahashi. "COMPARATIVE STUDIES ON ANTITHROMBIN III AFFINITY OF LOW MOLECULAR WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644365.
Texto completoBriel, R. C., P. C. Hermann y P. Doller. "LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) PROPHYLAXIS IN GYNECOLOGIC SURGERY". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643223.
Texto completoChong, B. H., F. Ismail, J. Cade, A. S. Gallus, S. Gordon y C. N. Chesterman. "HEPARIN-INDUCED THROMBOCYTOPENIA: IN VITRO STUDIES WITH LOW MOLECULAR WEIGHT HEPARINOID, ORG 10172". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643926.
Texto completoEmanuele, R. M. y J. Fareed. "THE EFFECT OF MOLECULAR WEIGHT ON THE RELATIVE BIOAVAILABILITY OF HEPARIN". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644179.
Texto completoInformes sobre el tema "Low molecular weight heparin"
Chen, Chen, Peng Chen, Xia Liu y Hua Li. Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients with Retinal Detachment. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, agosto de 2021. http://dx.doi.org/10.37766/inplasy2021.8.0117.
Texto completoWei, Qingqing, Weiying Wang, Guobin Miao, Li Li, Ge Wang, Chang Meng y Peng Liu. Aspirin Versus Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Patients after Postoperative Joint Surgery: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, febrero de 2023. http://dx.doi.org/10.37766/inplasy2023.2.0117.
Texto completoRungjirajittranon, Tarinee, Weerapat Owattanapanich, Yingyong Chinthammitr, Theera Ruchutrakool y Bundarika Suwanawiboon. Direct oral anticoagulants versus low-molecular-weight heparin for acute treatment of venous thromboembolism in patients with gastrointestinal cancer: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, agosto de 2021. http://dx.doi.org/10.37766/inplasy2021.8.0113.
Texto completoRoberts, Christine Cardinal, Alan Graham, Martin Nemer, Leslie M. Phinney, Robert M. Garcia, Melissa Marie Soehnel y Emily Kate Stirrup. Physical Properties of Low-Molecular Weight Polydimethylsiloxane Fluids. Office of Scientific and Technical Information (OSTI), febrero de 2017. http://dx.doi.org/10.2172/1343365.
Texto completoGao, H. Crosslinked, flexible, low-molecular-weight polyacrylamide gels for mobility control. Office of Scientific and Technical Information (OSTI), diciembre de 1989. http://dx.doi.org/10.2172/5405561.
Texto completoScharf, Michael E., Sam N. Nguyen, Cheol Song y Phillip G. Koehler. Bioassay for Volatile Low Molecular Weight Insecticides and Methods of Use. Fort Belvoir, VA: Defense Technical Information Center, julio de 2007. http://dx.doi.org/10.21236/ada605489.
Texto completoWoods, W. T. y Jr. Mechanisms of Action of Low Molecular Weight Toxins in the Cardiovascular System. Fort Belvoir, VA: Defense Technical Information Center, octubre de 1987. http://dx.doi.org/10.21236/ada225113.
Texto completoRen, Tong. Hydrolytic and Peroxyhydrolytic Degradation of Nerve Agent Analogs with Low Molecular Weight Bimetallic Catalysts. Fort Belvoir, VA: Defense Technical Information Center, enero de 2005. http://dx.doi.org/10.21236/ada429791.
Texto completoArenson, D. R. y C. J. King. Separation of low molecular weight alcohols from dilute aqueous solutions by reversible chemical complexation. Office of Scientific and Technical Information (OSTI), abril de 1989. http://dx.doi.org/10.2172/6094599.
Texto completoWingate, Hannah F. y Khandan Keyomarsi. The Role of the Low Molecular Weight (LMW) Isoforms of Cyclin E in Breast Cancer Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, junio de 2005. http://dx.doi.org/10.21236/ada443238.
Texto completo